Stock ADXN ADDEX THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Delayed Swiss Exchange
Other stock markets
 08:21:23 2024-04-29 am EDT 		5-day change 1st Jan Change
0.059 CHF -48.92% Intraday chart for Addex Therapeutics Ltd -61.69% +28.26%
01:57pm Top Premarket Decliners MT
01:38pm Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure DJ

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Premarket Decliners
MT
Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure
DJ
Addex Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Addex Therapeutics Logs Decline in FY23 Net Loss; Revenue Rises
MT
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
DJ
ADRs End Higher; Biophytis Climbs 30%
DJ
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data
MT
Top Premarket Gainers
MT
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%
DJ
Top Premarket Gainers
MT
Addex Therapeutics Announces the Launch of Neurosterix, Company Focused on Developing Allosteric Modulators for the Treatment of Underserved Neurological Disorders
CI
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
DJ
Addex to Present at the Swiss Equities Baader Conference
DJ
Addex Therapeutics Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Addex Therapeutics' ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
CI
Addex Therapeutics Restores Compliance with Nasdaq's Minimum Bid Price Requirement
MT
Addex Therapeutics Gets Nasdaq Nod for New American Depositary Share Ratio
MT
Addex-led Consortium Wins EUR4 Million Grant to Develop Mild Neurocognitive Disorders Drug
MT
Addex Therapeutics Ltd Announces ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Second Quarter 2024
CI
Addex Therapeutics Announces Data Published in Brain
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADXN Stock
  4. News Addex Therapeutics Ltd
  5. Highlights